Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagio Medical Holdings, Inc.ADGM · Entity 7926 | Director | June 16, 2026 | August 12, 2026 |
| Medtronic plcMDT · Entity 2888 | EVP & President Cardiovascular | December 16, 2024 | December 17, 2024 |
| TELEFLEX INCTFX · Entity 3798 | Director | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagio Medical Holdings, Inc.
Report date June 16, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2036-06-16 | Direct | 30,000 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 30,000 · Balance 30,000 F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Medtronic plc
Report date December 16, 2024 · Filed December 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 64,722 |
Reported balance
After 2024-12-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-12-16 · Tax withholding · Disposed 645 · Balance 64,722 F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2: Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility.
F2: Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person.
TELEFLEX INC
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 674 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 674 · Balance 674 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date. |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $137.00 · Expires 2036-09-08 | Direct | 4,444 |
Reported balance
After 2026-09-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-08 · Grant · Acquired 4,444 · Balance 4,444 F2: Stock Option Award vests 100% on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date.
F2: Stock Option Award vests 100% on the one-year anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 10, 2026 20:09 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 4,444 | $0.00 Strike: $137.00 | $0.00 |
DisclosureSEC source: 0000096943-26-000103 · wk-form4_1789070944.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,444 Underlying: Common Stock · 4,444 shares Expires 2036-09-08 F2 · derivative.exercise_date: Stock Option Award vests 100% on the one-year anniversary of the grant date. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:09 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-26-000103 · wk-form4_1789070944.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 674 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date. Read SEC document |
| June 16, 2026 Filed Aug 12, 2026 18:37 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001792380-26-000002 · form4-08122026_060834.xml · derivative · entry 1 Salmon Sean · CIK 0001792380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-16 F1 · security: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. F1 · derivative.exercise_date: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 02:51 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $0.88 | $0.00 |
DisclosureSEC source: 0001104659-25-120419 · tm2533316-2_4seq1.xml · derivative · entry 1 Salmon Sean · CIK 0001792380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2035-12-10 F1 · security: The shares subject to the option will vest in 36 equal monthly installments commencing on January 11, 2026, subject to the Reporting Person's continued services through each such date. F1 · derivative.exercise_date: The shares subject to the option will vest in 36 equal monthly installments commencing on January 11, 2026, subject to the Reporting Person's continued services through each such date. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 645 | $82.48 | $53,199.60 |
DisclosureSEC source: 0001613103-24-000178 · wk-form4_1734472797.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,722 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2 · balance_after: Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:14 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 5,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · derivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:14 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,779 | $81.51 | $226,516.29 |
DisclosureSEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · nonDerivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,110 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:14 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 657 | $81.51 | $53,552.07 |
DisclosureSEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,889 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:14 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 5,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000116 · wk-form4_1722982456.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents, of which 4,369 shares will be delivered to the reporting person when his employment with the Company ends. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:03 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 106,260 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000092 · wk-form4_1722470630.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,260 Underlying: Ordinary Shares · 106,260 shares Expires 2034-07-29 F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:03 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Unit · Derivative | 35,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000092 · wk-form4_1722470630.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,938 Underlying: Performance Share Units · 35,938 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Vests on July 29, 2027. F4 · derivative.expiration_date: Vests on July 29, 2027. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,938 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 00:03 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 14,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000092 · wk-form4_1722470630.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,084 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 420 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,035 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · derivative · entry 9 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 16,035 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,066 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · derivative · entry 8 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,066 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,594 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · derivative · entry 7 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,066 Underlying: Ordinary Shares · 1,594 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 16,035 | $85.12 | $1,364,899.20 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 6 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,289 F3 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 13,066 | $85.15 | $1,112,569.90 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 5 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,324 F2 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,594 | $85.06 | $135,585.64 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,390 Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 16,035 | $74.84 | $1,200,059.40 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 13,066 | $62.76 | $820,022.16 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 22:18 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,594 | $62.76 | $100,039.44 |
DisclosureSEC source: 0001613103-24-000008 · wk-form4_1708726707.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 19:54 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 435 | $79.27 | $34,482.45 |
DisclosureSEC source: 0001613103-23-000162 · wk-form4_1702410832.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,103 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2 · balance_after: Includes 812 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 5,604 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001613103-23-000097 · wk-form4_1691454000.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 5,604 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F4 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 3, 2023. F5 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,369 | $84.49 | $369,136.81 |
DisclosureSEC source: 0001613103-23-000097 · wk-form4_1691454000.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,726 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 8, 2023 00:20 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 5,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000097 · wk-form4_1691454000.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,095 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 201 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:53 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 68,196 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000076 · wk-form4_1691020401.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,196 Underlying: Ordinary Shares · 68,196 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:53 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 21,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000076 · wk-form4_1691020401.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,214 Underlying: Performance Share Unit · 21,214 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,214 shares will be issued. If maximum performance metrics are achieved, 48,428 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:53 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000076 · wk-form4_1691020401.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,290 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 516 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,823 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · derivative · entry 5 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,823 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,808 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · derivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,808 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 16,631 | $80.50 | $1,338,735.63 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · nonDerivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,088 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.48 to $80.545 inclusive. The reporting person undertakes to provide Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 14,823 | $55.32 | $820,008.36 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,808 | $55.32 | $100,018.56 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:45 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 300 | $79.04 | $23,712.00 |
DisclosureSEC source: 0001127602-22-027194 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,088 F1 · balance_after: This balance increased by 174 shares due to exempt acquisitions through dividend reinvestment. F2 · balance_after: The reported transaction involved the withholding of 300 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:41 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 67,924 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020417 · form4.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,924 Underlying: Ordinary Shares · 67,924 shares Expires 2032-08-01 F5 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:41 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 21,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020417 · form4.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,487 Underlying: Performance Share Units · 21,487 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,487 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F4 · derivative.exercise_date: Vests on August 1, 2025. F4 · derivative.expiration_date: Vests on August 1, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:41 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 8,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020417 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,214 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 21:38 UTC | Medtronic plc MDT · Entity 2888 | Disposition to issuerOrdinary Shares | 5,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020216 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,619 F1 · shares: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2 · balance_after: This balance increased by 344 shares due to exempt acquisitions through dividend reinvestment. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 23:31 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 89 | $104.94 | $9,339.66 |
DisclosureSEC source: 0001127602-21-031183 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,083 F1 · balance_after: The reported transaction involved the withholding of 89 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 23:05 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 245 | $122.98 | $30,130.10 |
DisclosureSEC source: 0001127602-21-028742 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,172 F1 · balance_after: The reported transaction involved the withholding of 245 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. F2 · balance_after: This balance increased by 88 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,713 | $0.00 Strike: $38.20 | $0.00 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · derivative · entry 8 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,713 shares Expires 2022-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,577 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · derivative · entry 7 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,577 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,129 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · derivative · entry 6 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 21,129 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 7,290 | $134.09 | $977,516.10 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · nonDerivative · entry 5 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,329 Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 4,713 | $38.20 | $180,036.60 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · nonDerivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 2,577 | $38.81 | $100,013.37 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · nonDerivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 21,129 | $134.08 | $2,832,976.32 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,329 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.05 to $134.16 inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 21,129 | $38.81 | $820,016.49 |
DisclosureSEC source: 0001127602-21-024367 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:24 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 13,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023105 · form4.xml · derivative · entry 5 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,714 Underlying: Performance Share Units · 13,714 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,714 shares will be issued. The actual number of shares to be issued could range from a low of 2,743 at minimum performance to a high of 27,428 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7 · derivative.exercise_date: Vests on August 2, 2024. F7 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:24 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023105 · form4.xml · derivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Ordinary Shares · 1,085 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.